Immunotherapy for KRAS positive lung adenocarcinoma: Mesothelin and CA125 (MUC16) are cancer-antigen targets Meeting Abstract


Authors: Hristov, B.; Eguchi, T.; Chintala, N.; Lu, S.; Bott, M.; Travis, W.; Jones, D.; Adusumilli, P.
Abstract Title: Immunotherapy for KRAS positive lung adenocarcinoma: Mesothelin and CA125 (MUC16) are cancer-antigen targets
Meeting Title: IASLC 17th World Conference on Lung Cancer
Keywords: metastasis; therapy; adoptive t cell; car-t cell; mesothelin-ca125 interaction
Journal Title: Journal of Thoracic Oncology
Volume: 12
Issue: 1 Suppl.
Meeting Dates: 2016 Dec 4-7
Meeting Location: Vienna, Austria
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2017-01-01
Start Page: S1457
Language: English
ACCESSION: WOS:000413055803328
PROVIDER: wos
DOI: 10.1016/j.jtho.2016.11.1988
Notes: Meeting Abstract: PUB018 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William D Travis
    743 Travis
  2. Matthew Bott
    135 Bott
  3. David Randolph Jones
    417 Jones
  4. Takashi   Eguchi
    71 Eguchi
  5. Shaohua   Lu
    23 Lu